Cited by — Chimeric antigen receptor T-cell therapy for refractory post-transplant lymphoproliferative disorder after lung transplantation | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Chimeric antigen receptor T-cell therapy for refractory post-transplant lymphoproliferative disorder after lung transplantation.
No admitted local citation edges point to this work yet.